Siva, Jayant https://orcid.org/0009-0002-8132-4332
Vallabhaneni, Sanjay
Jonnalagadda, Rishi
Heller, Nicholas
Barr, Andrew
Patel, Sahil
Naelitz, Bryan D. https://orcid.org/0000-0003-1963-8592
Lundy, Scott D. https://orcid.org/0000-0002-0127-4295
Bole, Raevti
Article History
Received: 3 March 2026
Revised: 8 April 2026
Accepted: 7 May 2026
First Online: 20 May 2026
Competing interests
: SDL is a paid consultant for Tolmar Pharmaceuticals. The remaining authors have no competing interests to disclose.
: All methods were performed in accordance with the relevant guidelines and regulations. Institutional review board approval was obtained (IRB #24-354), and informed consent was waived. No identifiable images from human research participants were used.